Home › Therapeutic areas › Oncology › Endometrial Cancer

Endometrial Cancer (8 companies)

Companies with an active program in Endometrial Cancer.

Ticker Company Therapeutic areas Programs Lead stage Mkt cap Programs
ACRV Acrivon Therapeutics GI/HepatologyOncology Rare 2 Phase 2 $61.4M 9
ANAB AnaptysBio DermatologyGI/Hepatology+2 Rare 1 Approved $1.36B 9
AVBP ArriVent BioPharma Oncology 1 Phase 3 $553M 7
CMPX Compass Therapeutics Oncology 1 Phase 2 $109M 15
CGEN Compugen Oncology 1 Phase 3 $191M 7
CBIO Crescent Biopharma Oncology 1 Phase 2 $507M 10
PMVP PMV Pharmaceuticals Oncology 1 Phase 2 $92.2M 7
ZYME Zymeworks OncologyRespiratory 1 Approved $1.78B 12